Phase III trials show XELOX equivalent to FOLFOX: Commentary Journal Article
| Author: | Lichtman, S. M. |
| Article Title: | Phase III trials show XELOX equivalent to FOLFOX: Commentary |
| Keywords: | cancer survival; survival rate; overall survival; clinical trial; neutropenia; bevacizumab; fluorouracil; placebo; cancer combination chemotherapy; diarrhea; drug efficacy; drug safety; drug withdrawal; capecitabine; adjuvant therapy; disease free survival; colorectal cancer; bolus injection; metastasis; quality of life; multiple cycle treatment; bone marrow suppression; neuropathy; thrombocytopenia; combination chemotherapy; antineoplastic activity; continuous infusion; irinotecan; febrile neutropenia; loading drug dose; standard; folinic acid; drug response; patient compliance; short survey; drug substitution; oxaliplatin; drug treatment failure; hand foot syndrome; drug choice |
| Journal Title: | The Oncology Report |
| Issue: | Fall |
| ISSN: | 1548-5323 |
| Publisher: | International Medical News Group LLC |
| Date Published: | 2007-09-01 |
| Start Page: | 33 |
| Language: | English |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 17 November 2011" - "Source: Scopus" |
MSK Authors
-
228Lichtman